scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...9011312H |
P356 | DOI | 10.1073/PNAS.90.23.11312 |
P932 | PMC publication ID | 47972 |
P698 | PubMed publication ID | 8248245 |
P5875 | ResearchGate publication ID | 14951536 |
P2093 | author name string | Takagi Y | |
Harada N | |||
Utsumi T | |||
P2860 | cites work | Rapid restriction mapping of DNA cloned in lambda phage vectors | Q72405834 |
Regulation of Aromatase Activity of Stromal Cells Derived from Human Adipose Tissue* | Q72675881 | ||
DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein | Q28117051 | ||
Characterization of the human parathyroid hormone-like peptide gene. Functional and evolutionary aspects | Q28118931 | ||
Structural and functional characterization of human aromatase P-450 gene | Q28646465 | ||
At least three promoters direct expression of the mouse glucocorticoid receptor gene | Q31046854 | ||
A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts | Q33196764 | ||
Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line | Q33257751 | ||
Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta | Q33560332 | ||
Human aldolase A gene. Structural organization and tissue-specific expression by multiple promoters and alternate mRNA processing | Q34177308 | ||
Structural characterization of the human estrogen synthetase (aromatase) gene | Q34424469 | ||
Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation | Q35831379 | ||
Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis | Q36422031 | ||
Primary cultures of ovarian cells in serum-free medium as models of hormone-dependent differentiation | Q40105820 | ||
Modulation of steroidogenesis in choriocarcinoma cells by cholera toxin, phorbol ester, epidermal growth factor and insulin-like growth factor I. | Q42515986 | ||
Prognostic value of breast cancer aromatase | Q43824571 | ||
Tissue-Specific Promoters Regulate Aromatase Cytochrome P450 Gene Expression in Human Ovary and Fetal Tissues | Q48198807 | ||
Isolation and characterization of the human gonadotropin-releasing hormone gene in the hypothalamus and placenta | Q48273519 | ||
Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis | Q48282408 | ||
An alternate promoter in the glucokinase gene is active in the pancreatic beta cell | Q48286873 | ||
Aromatization of Androstenedione by the Anterior Hypothalamus of Adult Male and Female Rats | Q51109778 | ||
Conversion of androstenedione to estrone by human tissue. | Q55061731 | ||
Aromatase activity in breast tissue | Q68062064 | ||
Aromatase activity in microsomal preparations of human genital skin fibroblasts: influence of glucocorticoids | Q69726714 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | carcinogenesis | Q1637543 |
P304 | page(s) | 11312-11316 | |
P577 | publication date | 1993-12-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis | |
P478 | volume | 90 |
Q30804119 | A GCM motif protein is involved in placenta-specific expression of human aromatase gene |
Q31946994 | A common protocadherin tail: multiple protocadherins share the same sequence in their cytoplasmic domains and are expressed in different regions of brain |
Q34187475 | A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse. |
Q37222219 | A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. |
Q40853899 | A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells |
Q73867503 | Aberrant expression of aromatase in breast cancer tissues |
Q28201872 | Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding [...] |
Q37285287 | Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) alpha in breast cancer cells: identification of a novel ROR response element |
Q44730458 | Acute effects of testosterone on intracellular Ca2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens |
Q46970368 | Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2. |
Q37360182 | Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years |
Q42849265 | An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors |
Q77648510 | Analysis of transcriptional regulation of human breast aromatase by in vitro and in vivo studies |
Q34181103 | Are aromatase inhibitors effective in endometriosis treatment? |
Q44229610 | Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development |
Q36136513 | Aromatase cytochrome P450 gene expression in endometrial carcinoma |
Q48949860 | Aromatase distribution and regulation in fish. |
Q36710458 | Aromatase distribution in the monkey temporal neocortex and hippocampus |
Q37398191 | Aromatase excess in cancers of breast, endometrium and ovary |
Q41012816 | Aromatase expression and activity in the human leukaemic cell line FLG 29.1 |
Q48376891 | Aromatase expression in human peripheral blood leucocytes (PBLs) and in various tissues in primates: studies in elderly humans and cynomolgus monkeys |
Q50936551 | Aromatase in Human Bone Tissue |
Q43890523 | Aromatase in atherosclerotic lesions of human aorta |
Q35782265 | Aromatase in human common epithelial ovarian neoplasms. |
Q39113068 | Aromatase in human liver and its diseases |
Q54774968 | Aromatase in skeletal muscle. |
Q48474591 | Aromatase in the human central nervous system |
Q35605450 | Aromatase inhibitors for breast cancer: lessons from the laboratory |
Q43890510 | Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology |
Q36191587 | Aromatase, breast cancer and obesity: a complex interaction |
Q33856931 | Aromatase, oestrogens and human male reproduction |
Q82906523 | Association of CYP19 Gene Polymorphism with Vertebral Fractures in Japanese Postmenopausal Women |
Q51154398 | Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women |
Q24685808 | Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans |
Q92938624 | Basal teleosts provide new insights into the evolutionary history of teleost-duplicated aromatase |
Q35971794 | Behavioral Analysis of Genetically Modified Mice Indicates Essential Roles of Neurosteroidal Estrogen |
Q77493094 | Biochemical control of breast aromatase |
Q35612285 | Biological rationale for endocrine therapy in breast cancer |
Q34299734 | Biology of aromatase in the mammary gland |
Q74472278 | Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction |
Q77354233 | Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function |
Q46672264 | Characterization of a Silencer Element in the Human Aromatase Gene |
Q36891404 | Characterization of the promoter of human adipocyte hormone-sensitive lipase |
Q73569175 | Chromatin structure of the bovine Cyp19 promoter 1.1. DNaseI hypersensitive sites and DNA hypomethylation correlate with placental expression |
Q48352457 | Cloning of brain aromatase gene and expression of brain and ovarian aromatase genes during sexual differentiation in genetic male and female Nile tilapia Oreochromis niloticus |
Q48049073 | Closely Related Genes Encode Developmental and Tissue Isoforms of Porcine Cytochrome P450 Aromatase |
Q40789660 | Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells |
Q36618233 | Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk |
Q73867527 | Cooperative regulation of the human aromatase cytochrome P450 gene transcription by placenta-specific cis-acting elements |
Q37777053 | Current, new and future treatments of osteoporosis |
Q44014868 | Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihy |
Q47989622 | Different promoter usage for CYP19 gene expression in buffalo ovary and placenta |
Q73719433 | Distinct expression of splice variants of neuronal nitric oxide synthase in the human gastrointestinal tract |
Q77367211 | Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy |
Q52558965 | Effects of Neonicotinoid Pesticides on Promoter-Specific Aromatase (CYP19) Expression in Hs578t Breast Cancer Cells and the Role of the VEGF Pathway |
Q47850402 | Embryonic brain-gonadal axis in temperature-dependent sex determination of reptiles: A role for P450 aromatase (CYP19) |
Q59072640 | Endocrine Resistance in Breast Cancer |
Q37828063 | Estrogen and androgen signaling in the pathogenesis of BPH. |
Q40999358 | Estrogen biosynthesis in adipose. Significance in breast cancer development |
Q44555481 | Estrogen receptor alpha and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women |
Q28649589 | Estrogen receptor signaling during vertebrate development |
Q36677805 | Estrogen synthesis and signaling pathways during aging: from periphery to brain |
Q36890444 | Evolutionary and functional significance of two CYP19 genes differentially expressed in brain and ovary of goldfish |
Q48685433 | Expression of the aromatase cytochrome P450 encoding gene in cattle and sheep |
Q37620962 | Fish with thermolabile sex determination (TSD) as models to study brain sex differentiation |
Q74453724 | From Endocrinology to Intracrinology |
Q41640195 | Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells |
Q34460484 | Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk |
Q73540247 | Genetic variants of CYP19 (aromatase) and breast cancer risk |
Q37384632 | Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China |
Q48805548 | Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein |
Q34935090 | HRT and cancer risks |
Q32121425 | Identification and Tissue Distribution of Human Cystathionine β-Synthase mRNA Isoforms |
Q46660019 | Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells |
Q77463275 | Immunolocalization of aromatase in human minor salivary glands of the lower lip with primary Sjogren's syndrome |
Q92378297 | Impact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots |
Q38220763 | Impact of obesity on mammary gland inflammation and local estrogen production. |
Q36649092 | Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts |
Q36801801 | Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish |
Q77481740 | Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies* |
Q24794121 | Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer |
Q34124220 | Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction |
Q50109273 | Inversion of genetic predisposition to carcinogenesis in liver of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis |
Q39206981 | Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose. |
Q44722784 | Isolation and characterization of cyp19a1a and cyp19a1b promoters in the protogynous hermaphrodite orange-spotted grouper (Epinephelus coioides) |
Q28504939 | LIM‐Homeodomain Transcription Factor, Lhx2, is involved in Transcriptional Control of Brain‐Specific Promoter/Exon 1f of the Mouse Aromatase Gene |
Q36909294 | Letrozole: present and future role in the treatment of breast cancer |
Q34121545 | Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes |
Q47330474 | Low-dose bisphenol A activates the ERK signaling pathway and attenuates steroidogenic gene expression in human placental cells |
Q34563377 | Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. |
Q50449761 | Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers |
Q21285026 | Molecular Bases and Phenotypic Determinants of Aromatase Excess Syndrome |
Q77493098 | Molecular analysis of aberrant expression of aromatase in breast cancer tissues |
Q41116946 | Molecular aspects of brain aromatase cytochrome P450 |
Q32075010 | Multiple Splicing Events Involved in Regulation of Human Aromatase Expression by a Novel Promoter, I.6* |
Q34034301 | Neurochemical characterization and sexual dimorphism of projections from the brain to abdominal and subcutaneous white adipose tissue in the rat. |
Q43708429 | Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers |
Q38290925 | Organization of the Human N‐Acetylglucosaminyltransferase V Gene |
Q36215989 | Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. |
Q45755683 | P450arom gene expression in peripheral blood lymphocytes: Identification of a cryptic splice site for exon-1 afterEpstein–Barr virus transformation |
Q36303977 | PPARγ Agonists Target Aromatase Via Both PGE2 and BRCA1 |
Q43890559 | Phylogeny, expression and enzyme activity of zebrafish cyp19 (P450 aromatase) genes |
Q36772834 | Polymorphisms in the CYP19 gene that influence bone mineral density |
Q41640237 | Porcine aromatases: studies on tissue-specific, functionally distinct isozymes from a single gene? |
Q46879111 | Possible involvement of aromatase overexpression induced by cyclo-oxygenase-2 in the pathogenesis of idiopathic gynecomastia |
Q38962666 | Post-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation |
Q73049304 | Presence of exon I.4 mRNA from CYP19 gene in human granulosa cells |
Q46500936 | Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls |
Q24803037 | Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast |
Q35735618 | RNA diversity has profound effects on the translation of neuronal nitric oxide synthase |
Q40750401 | Regulation of aromatase by nuclear receptors |
Q30833943 | Regulation of aromatase promoter activity in human breast tissue by nuclear receptors |
Q38249880 | Regulation of local steroidogenesis in the brain and in prostate cancer: lessons learned from interdisciplinary collaboration. |
Q42799719 | Role of CRE-binding protein (CREB) in aromatase expression in breast adipose |
Q51762188 | Sex, metabolism and health |
Q57460030 | Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model |
Q51283993 | Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis |
Q28185149 | Sources of estrogen and their importance |
Q48732115 | Structure of aromatase mRNA in the rat brain |
Q34066255 | The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription1 |
Q33934350 | The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression |
Q38727579 | The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview. |
Q24802322 | The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer |
Q33944872 | The role of local estrogen biosynthesis in males and females |
Q37372623 | Tissue- and development-specific expression of multiple alternatively spliced transcripts of rat neuronal nitric oxide synthase |
Q32170627 | Tissue-Specific Expression and Alternative Splicing of Human Microsomal Epoxide Hydrolase |
Q33577548 | Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy |
Q48685469 | Tissue-specific expression of the human CYP19 (aromatase) gene in ovary and adipose tissue of transgenic mice |
Q51548252 | Tissue-specific promoter methylation and histone modification regulate CYP19 gene expression during folliculogenesis and luteinization in buffalo ovary |
Q73867520 | Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture |
Q28505915 | Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life |
Q60923104 | Treating prostate cancer: a rationale for targeting local oestrogens |
Q35586795 | Unique regulation of expression of human aromatase in the placenta |
Q44659450 | Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice |
Q28585426 | cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase |
Search more.